Skip to main content
. Author manuscript; available in PMC: 2019 Aug 8.
Published in final edited form as: Leukemia. 2019 Feb 8;33(7):1620–1634. doi: 10.1038/s41375-019-0390-3

Table 2.

Comparison of pretreatment characteristics between patients with acute myeloid leukemia with typical and those with atypical complex karyotype

Characteristic Atypical CK n=40 Typical CK n=96 P-valuea
Age, years 0.007
 Median 53 59
 Range 18-77 30-84

Sex, n (%) 0.23
 Male 30 (75) 61 (64)
 Female 10 (25) 35 (36)

Race, n (%) 0.78
 White 34 (85) 79 (88)
 Non-white 6 (15) 11 (12)

Hemoglobin, g/dl 0.14
 Median 9.5 9.0
 Range 5.5-14.4 6.0-14.7

Platelet count, ×109/l 0.96
 Median 54 49
 Range 6-376 4-323

WBC count, ×109/l 0.001
 Median 23.8 6.0
 Range 0.8-225.3 0.7-137.6

Bone marrow blasts, % <0.001
 Median 76 46
 Range 20-92 13-97

Blood blasts, % 0.006
 Median 59 28
 Range 0-98 0-99

Extramedullary involvement, n (%) 9 (24) 10 (11) 0.06

Number of chromosome abnormalities <0.001
 Median 4 9
 Range 3-15 3-33

Abbreviations: CK, complex karyotype; WBC, white blood cell.

a

P-values for categorical variables are from Fisher’s exact test, P-values for continuous variables are from Wilcoxon rank sum test.